Clinical Trials

Showing 181 - 200 of 514 trials
Titlesort icon Investigator Disease(s)
A Phase IB Study of SAR650984 with Lenalidomide and Dexamethasone to Treat Recurrent or Persistent Multiple Myeloma
[Protocol 13-006]
Lendvai, Nikoletta
  • Hematology
    • Multiple Myeloma
A Phase IB Study of Urelumab (BMS-663513) plus Cetuximab in Patients with Persistent Head and Neck or Colorectal Cancer
[Protocol 14-121]
Segal, Neil
  • Colorectal Cancer
  • Head & Neck Cancer
A Phase Ib Study of Urelumab Given with Rituximab in Patients with Recurrent or Persistent Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
Relapsed/Refractory
[Protocol 13-252]
Zelenetz, Andrew
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase Ib/II Study of LGX818 and Cetuximab with or without BYL719 in Patients with BRAF-Mutant Metastatic Colorectal Cancer
[Protocol 14-019]
Yaeger, Rona
  • Colorectal Cancer
A Phase Ib/II Study of MEK162 plus Panitumumab in Patients with Metastatic Colorectal Cancer
[Protocol 14-044]
Yaeger, Rona
  • Colorectal Cancer
A Phase Ib/II Study of MEK162 with Imatinib in Patients with Untreated Advanced Gastrointestinal Stromal Tumor
[Protocol 13-162]
Chi, Ping
  • Sarcomas
  • Upper Gastrointestinal
A Phase Ib/II Study of OMP-59R5 plus Etoposide and Cisplatin in Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer
[Protocol 13-125]
Pietanza, M. Catherine
A Phase IB/II Study of OMP-59R5 with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer
[Protocol 12-234]
O'Reilly, Eileen
  • Hepatobiliary
    • Pancreatic Cancer
  • Upper Gastrointestinal
    • Pancreatic Cancer
A Phase IB/IIA Study of Carfilzomib, Romidepsin, and Lenalidomide in Patients with Recurrent or Persistent Lymphoma
[Protocol 14-179]
Horwitz, Steven
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase IB/IIA Study of Romidepsin plus Lenalidomide in Adults with Relapsed or Refractory Lymphoma and Myeloma
Relapsed/Refractory
[Protocol 12-170]
Horwitz, Steven
  • Hematology
    • Multiple Myeloma
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study Assessing Contrast-Enhanced MRI to Evaluate Response to Radiation Treatment for Prostate Cancer
Newly Diagnosed & Relapsed/Refractory
[Protocol 14-172]
Zelefsky, Michael
  • Prostate Cancer
    • Localized Disease
A Phase II Study Assessing PET/CT Scanning to Guide Radiation Treatment for Inoperable Stage III Non-Small Cell Lung Cancer
[Protocol 14-032]
Gelblum, Daphna
  • Lung Cancer, Non-Small Cell
A Phase II Study Comparing Romiplostim with Observation for Chemotherapy-Induced Thrombocytopenia
[Protocol 13-132]
Soff, Gerald
  • Hematology
    • Hematologic Disorders
  • Solid Tumors
A Phase II Study Comparing Three Months versus Two Years of Afatinib Therapy after Surgery for Patients with Stage I-III Non-Small Cell Lung Cancer
[Protocol 13-096]
Chaft, Jamie
  • Lung Cancer, Non-Small Cell
A Phase II Study Comparing Three New Approaches for Preventing Graft-versus-Host Disease
[Protocol 14-197]
Giralt, Sergio
  • Blood & Marrow Stem Cell Transplantation
    • Post-Transplant
  • Blood and Marrow Transplantation
    • Transplantation
  • Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV
[Protocol 11-130]
O'Reilly, Richard
  • Blood and Marrow Transplantation
    • Transplantation
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase II Study of 5'-Azacitidine to Prevent Recurrence in Patients Who Had a Donated Stem Cell Transplant for Acute Myeloid Leukemia or Myelodysplastic Syndromes
[Protocol 13-192]
Tamari, Roni
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
A Phase II Study of a Pediatric-Inspired Combination Chemotherapy Regimen in Adults with Acute Lymphoblastic Leukemia
[Protocol 12-266]
Douer, Dan
A Phase II Study of Abiraterone Acetate without Simultaneous Prednisone in Men with Castration-Resistant Prostate Cancer, with Hormonal Assessment During Treatment
[Protocol 14-188]
Morris, Michael
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy
A Phase II Study of Abiraterone with or without Cabazitaxel in Patients with Metastatic Castration-Resistance Prostate Cancer
[Protocol 14-046]
Slovin, Susan
  • Prostate Cancer
    • Metastatic Disease after Hormone-Reducing Therapy